- Home
- BXC vs ETON Comparison
BXC vs ETON Comparison
Compare BXC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXC
- ETON
- Stock Information
- Founded
- BXC 2004
- ETON 2017
- Country
- BXC United States
- ETON United States
- Employees
- BXC N/A
- ETON N/A
- Industry
- BXC Wholesale Distributors
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- BXC Consumer Discretionary
- ETON Health Care
- Exchange
- BXC Nasdaq
- ETON Nasdaq
- Market Cap
- BXC 443.9M
- ETON 498.8M
- IPO Year
- BXC 2004
- ETON 2018
- Fundamental
- Price
- BXC $63.77
- ETON $16.15
- Analyst Decision
- BXC Strong Buy
- ETON Strong Buy
- Analyst Count
- BXC 3
- ETON 3
- Target Price
- BXC $88.67
- ETON $29.67
- AVG Volume (30 Days)
- BXC 108.2K
- ETON 323.4K
- Earning Date
- BXC 11-04-2025
- ETON 11-06-2025
- Dividend Yield
- BXC N/A
- ETON N/A
- EPS Growth
- BXC N/A
- ETON N/A
- EPS
- BXC 1.71
- ETON N/A
- Revenue
- BXC $2,948,840,000.00
- ETON $70,316,000.00
- Revenue This Year
- BXC $1.54
- ETON $105.25
- Revenue Next Year
- BXC $4.30
- ETON $40.84
- P/E Ratio
- BXC $36.31
- ETON N/A
- Revenue Growth
- BXC N/A
- ETON 102.77
- 52 Week Low
- BXC $52.71
- ETON $11.09
- 52 Week High
- BXC $130.06
- ETON $23.00
- Technical
- Relative Strength Index (RSI)
- BXC 52.09
- ETON 37.62
- Support Level
- BXC $53.71
- ETON $15.62
- Resistance Level
- BXC $60.42
- ETON $16.89
- Average True Range (ATR)
- BXC 3.02
- ETON 0.98
- MACD
- BXC 0.94
- ETON -0.10
- Stochastic Oscillator
- BXC 89.20
- ETON 13.87
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.